BIOMAT Database Logo BIOMAT Database Logo

In vitro B cell response in long-term renal transplant recipients. 1992

R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
Department of Transplantation Immunology, University of Heidelberg, Germany.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft

Related Publications

R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
In vitro immunoglobulin production in long-term renal transplant recipients.
April 1985, Transplantation,
R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
Cortisol pharmacodynamic response to long-term methylprednisolone in renal transplant recipients.
January 1994, Pharmacotherapy,
R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
Long-term outcome in hepatitis B sero-positive oriental renal transplant recipients.
January 2001, Transplantation proceedings,
R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
[Long-term management of renal transplant recipients].
January 2008, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
Anemia among long-term renal transplant recipients.
January 2008, Transplantation proceedings,
R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
CD4 lymphocytopenia in long-term renal transplant recipients.
September 1998, Transplantation proceedings,
R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
January 2005, Antiviral therapy,
R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B.
November 2004, European journal of gastroenterology & hepatology,
R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
Functional vitamin B-6 status and long-term mortality in renal transplant recipients.
December 2017, The American journal of clinical nutrition,
R Weimer, and S Zipperle, and V Daniel, and S Pomer, and G Staehler, and G Opelz
Long-term renal function after pregnancy in renal transplant recipients.
January 1997, Transplantation proceedings,
Copied contents to your clipboard!